Method of making steamed flour products using thermostable glucoamylase
By using heat-stabilized glucoamylase combined with specific variants in steamed flour products, the problem of degradation of quality after storage and re-steaming of steamed flour products is solved, and better preservation and sensory performance are achieved.
Patent Information
- Application Number
- CN202280095192.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-04-24
- Filing Date
- 2022-11-30
- Publication Date
- 2024-12-03
AI Technical Summary
After the steamed flour products are stored and re-steamed, there are problems such as aging, increasing hardness, changing appearance and color, and reducing chewing properties, which are difficult to effectively extend their shelf life and improve quality.
Using heat-stabilized glucoamylase, steaming is performed to prepare steamed flour products by combining with variants with high identity to specific glucoamylases in the dough or batter, improving their storage and re-steaming. softness, whiteness, elasticity and sweetness.
It significantly improves the fresh preservation performance and anti-aging ability of steamed flour products, reduces the hardness after storage, and improves the sensory evaluation after re-steaming, including softness, elasticity, appearance whiteness, pulp structure and sweetness.
Smart Images

Figure BDA0005095185960000181 
Figure BDA0005095185960000231 
Figure BDA0005095185960000241
Abstract
Description
[0001] References to sequence listings
[0002] This application contains a Sequence Listing in computer readable form, which is incorporated herein by reference. Technical Field
[0003] The present invention relates to an enzymatic method for preparing a steamed flour-based product, in particular to a method for preparing a steamed flour-based product (such as steamed bread) using a thermostable glucoamylase. Background Art
[0004] Steamed flour products such as steamed buns are one of the traditional staple foods of the Chinese, especially in northern China. In recent years, with the development of industrialization of the food industry, the industrialized production of steamed flour products has gradually increased.
[0005] WO 2011 / 039324 discloses a method for preparing steamed bread, comprising the steps of preparing dough for preparing steamed bread with one or more maltogenic α-amylases, one or more raw starch degrading enzymes and at least one lipolytic enzyme, wherein the enzymatic method delays the aging of the steamed bread product.
[0006] In daily life, people often buy / make multiple steamed buns at a time and eat them several times. After the steamed buns are stored at room temperature, low temperature or frozen for a period of time, they often need to be re-steamed before being eaten again to restore their softness and taste. However, re-steaming has a negative impact on the crumb structure, appearance color, chewiness and / or elasticity of steamed flour products.
[0007] Therefore, although some progress has been made in extending the shelf life of steamed bread using enzyme treatment, there is still a need to provide new enzyme solutions to improve the freshness preservation or anti-staling properties of steamed flour products, even if such steamed flour products need to be re-steamed. Summary of the invention
[0008] The inventors found that the thermostable glucoamylase of the present invention exhibits significantly improved performance in the preservation or anti-aging of steamed flour products (eg, steamed bread) prepared by the step of steaming dough.
[0009] Another improved property of the thermostable glucoamylases of the invention is that they unexpectedly and significantly improve the quality of steamed flour products after re-steaming, such as improving the appearance whiteness, softness, elasticity, crumb structure, and / or cohesiveness of the re-steamed product.
[0010] Another improved property of the thermostable glucoamylases of the present invention is that they increase the sweetness or sweet taste of the product, with natural sweetness being the preferred taste, thereby also reducing the amount of added sugar in traditional recipes.
[0011] Accordingly, in a first aspect, a method for producing a steamed flour product comprises:
[0012] a) providing a dough or batter comprising flour and a glucoamylase having at least 70% identity to SEQ ID NO: 1, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8; and
[0013] b) steaming the dough or the batter to produce a steamed flour product.
[0014] In a preferred embodiment of the present invention, the glucoamylase is a mature thermostable variant of a parent glucoamylase.
[0015] A second aspect of the invention relates to a dough premix or batter premix comprising a dough or batter as defined in the present invention and a mature thermostable variant of a parent glucoamylase.
[0016] In a preferred embodiment of the present invention, the steamed flour product of the present invention has reduced hardness and / or improved elasticity, and thus improved storage stability, compared to otherwise identical conditions but without the addition of enzymes to the dough / batter.
[0017] In a preferred embodiment of the present invention, the steamed flour product of the present invention has improved sensory evaluation after storage (preferably for a period of time) at room temperature or low temperature compared to other conditions being the same but without adding enzymes to the dough / batter.
[0018] In a preferred embodiment of the present invention, the steamed flour product after re-steaming has improved sensory evaluation compared to other conditions being the same but without adding enzymes to the dough / batter.
[0019] In a preferred embodiment of the present invention, the sensory evaluation is a comprehensive evaluation of the softness, elasticity, surface whiteness, crumb structure, moistness, cohesiveness, chewiness and / or sweetness of the steamed flour product, preferably an average value.
[0020] Preferably, the glucoamylase of the invention has at least 71% identity to SEQ ID NO: 1, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8, NO:8 has, for example, at least 72%, for example at least 73%, for example at least 74%, for example at least 75%, for example at least 76%, for example at least 77%, for example at least 78%, for example at least 79%, for example at least 80%, for example at least 81%, for example at least 82%, for example at least 83%, for example at least 84%, for example at least 85%, for example at least 86%, for example at least 87%, for example at least 88%, for example at least 89%, for example at least 90%, for example at least 91%, for example at least 92%, for example at least 93%, for example at least 94%, for example at least 95%, for example at least 96%, for example at least 97%, for example at least 98%, for example at least 99% identity, more preferably, the glucoamylase is a mature thermostable variant of the parent glucoamylase. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1 A multiple alignment of the amino acid sequences of the following mature proteins is shown:
[0022] - Wild-type AMG from Penicillium oxalicum (PoAMG) of SEQ ID NO: 1
[0023] - PoAMG variant denoted "AMG NL" of SEQ ID NO: 2
[0024] - A PoAMG variant of SEQ ID NO: 3 denoted "AMG anPAV498"
[0025] - PoAMG variant denoted "AMG JPO001" of SEQ ID NO:4
[0026] - A PoAMG variant of SEQ ID NO:5 designated as "AMG JPO124"
[0027] - PoAMG variant denoted "AMG JPO172" of SEQ ID NO:6
[0028] - Wild-type AMG from Penicillium miczynskii (PoAMG) of SEQ ID NO: 7
[0029] - Wild-type AMG from Penicillium russellii (PoAMG) of SEQ ID NO: 8
[0030] - Wild-type AMG from Penicillium glabrum (PoAMG) of SEQ ID NO: 9 DETAILED DESCRIPTION
[0031] definition
[0032] In light of this detailed description, the following definitions apply. Note that the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise.
[0033] Throughout this document, values expressed in range form should be interpreted in a flexible manner to include not only the values explicitly listed as range limits, but also all individual values or subranges encompassed within the range, as if each value and subrange were explicitly listed. For example, a range of "about 0.1% to about 5%" or "about 0.1% to 5%" should be interpreted to include not only about 0.1% to about 5%, but also individual values (e.g., 1%, 2%, 3%, and 4%) and subranges (e.g., 0.1% to 0.5%, 1.1% to 2.2%, 3.3% to 4.4%) within the indicated range. Unless otherwise specified, the statement "about X to Y" has the same meaning as "about X to about Y". Similarly, the statement "about X, Y, or about Z" has the same meaning as "about X, about Y, or about Z", unless otherwise specified.
[0034] Unless defined otherwise or clearly indicated by the context, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
[0035] Glucoamylase: The term glucoamylase (1,4-α-D-glucan glucanohydrolase, EC 3.2.1.3) is defined as an enzyme that catalyzes the release of D-glucose from the non-reducing ends of starch or related oligo- and polysaccharide molecules. Glucoamylases are also known as amyloglucosidases and glucan 1,4-α-glucosidases (EC 3.2.1.3), more commonly they are referred to as AMG. A glucoamylase unit (AGU) is defined as the amount of enzyme that hydrolyzes 1 micromole of maltose per minute under the following standard conditions: 37°C, pH 4.3, substrate: maltose 23.2 mM, buffer: acetate 0.1 M, reaction time 5 minutes.
[0036] Parent or parent glucoamylase: The term "parent" glucoamylase as used herein means a glucoamylase that is modified to produce a variant glucoamylase of the present invention. The term also refers to a polypeptide to which a variant of the present invention is compared. A parent can be a naturally occurring (wild-type) polypeptide, or it can even be a variant thereof prepared by any suitable means. For example, a parent protein can be a variant of a naturally occurring polypeptide that has been modified or altered in terms of amino acid sequence. Therefore, a parent glucoamylase can have one or more (or one or several) amino acid substitutions, deletions and / or insertions. Therefore, a parent glucoamylase can be a variant of a parent glucoamylase. A parent can also be an allelic variant, which is a polypeptide encoded by any of two or more alternative forms of a gene occupying the same chromosomal locus.
[0037] Mature polypeptide: The term "mature polypeptide" is defined herein as a biologically active polypeptide in its final form after translation and any post-translational modifications (such as N-terminal processing, C-terminal truncation, glycosylation, phosphorylation, etc.). The mature polypeptide sequence lacks a signal sequence, which can be determined using techniques known in the art (see, e.g., Zhang and Henzel, 2004, Protein Science 13: 2819-2824). The term "mature polypeptide coding sequence" means a polynucleotide encoding a mature polypeptide.
[0038] Sequence identity: The relatedness between two amino acid sequences or between two nucleotide sequences is described by the parameter "sequence identity".
[0039] For the purposes of the present invention, the sequence identity between two amino acid sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453), as implemented in the Needle program of the EMBOSS software package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, Trends Genet. 16: 276-277) (preferably version 5.0.0 or later). The parameters used are a gap opening penalty of 10, a gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix. The output of the "longest identity" labeled by Needle (obtained using the non-simplified (-nobrief) option) is used as the identity percentage and is calculated as follows:
[0040] (number of identical residues x 100) / (alignment length - total number of gaps in the alignment)
[0041] Variant: The term "variant" means a polypeptide having glucoamylase activity comprising an alteration, i.e., a substitution, insertion and / or deletion at one or more (e.g., several) positions. Substitution means replacing the amino acid occupying a position with a different amino acid; deletion means removing the amino acid occupying a position; and insertion means adding an amino acid adjacent to and immediately following the amino acid occupying a position. Variants of the invention have at least 20%, e.g., at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, or at least 100% of the glucoamylase activity of the polypeptide of SEQ ID NO: 1, SEQ ID NO: 6, SEQ ID NO: 7, or SEQ ID NO: 8.
[0042] Sensory evaluation: For sensory evaluation, a panel (eg, at least 3 trained persons) evaluated the quality of the steamed product.
[0043] Improved softness of steamed products: The term "improved softness of steamed products" is the opposite of "firmness / hardness" and is defined herein as the property of a steamed product that is more easily compressible compared to a control and is assessed empirically by trained personnel using the hands or mouth or measured, for example, by a texture analyser known in the art (e.g., TAXT2 or TA-XT Plus from Stable Micro Systems Ltd, Surrey, UK).
[0044] Improved elasticity of steamed products: The term "improved elasticity of steamed products" is defined herein as the property of a steamed product that returns to its original state more easily after being compressed compared to a control, and is assessed empirically by trained personnel using the hands or mouth or measured, for example, by a texture analyzer known in the art (e.g., TAXT2 or TA-XT Plus from Stable Micro Systems Ltd, Surrey, UK).
[0045] Improved whiteness appearance of steamed products: The term "improved whiteness appearance of steamed products" is defined herein as the property of a steamed product having a whiter surface appearance compared to a control and is typically assessed visually by trained personnel.
[0046] Improved crumb structure of steamed products: The term "improved crumb structure of steamed products" is defined herein as the property of a steamed product having finer cells and / or thinner cell walls in the crumb, and / or a more uniform / homogeneous distribution of cells in the crumb compared to a control, and is typically assessed visually by trained personnel.
[0047] Improved moistness of a steamed product: The term "improved moistness of a steamed product" is defined herein as the property of a steamed product having a cool touch or cool mouthfeel compared to a control, and is typically assessed empirically by trained personnel.
[0048] Improved cohesiveness of steamed product: The term "improved cohesiveness of steamed product" is defined herein as the property of a steamed product having less crumb fall-off compared to a control, and is typically assessed empirically by trained personnel.
[0049] Improved chewiness of steamed products: The term "improved chewiness of steamed products" is defined herein as the property of a steamed product requiring more chewing before swallowing compared to a control, and is typically assessed empirically by a skilled baker.
[0050] Improved sweetness of a steamed product: The term "improved sweetness of a steamed product" is defined herein as the property of a steamed product tasting sweeter compared to a control and is typically assessed by trained personnel.
[0051] Improved thermostability: Thermostability improvement (Td) in °C is a measure of how much a variant is improved in thermostability relative to its parent glucoamylase under the same conditions, determined as exemplified herein.
[0052] Nomenclature
[0053] For the purposes of the present invention, the nomenclature [Y / F] means that the amino acid at this position can be tyrosine (Try, Y) or phenylalanine (Phe, F). Similarly, the nomenclature [V / G / A / I] means that the amino acid at this position can be valine (Val, V), glycine (Gly, G), alanine (Ala, A) or isoleucine (Ile, I), and so on for other combinations as described herein. Unless otherwise indicated, amino acid X is defined such that it can be any of the 20 natural amino acids.
[0054] Variant naming conventions
[0055] For the purposes of the present invention, the polypeptide disclosed in SEQ ID NO: 1 is used to identify the corresponding amino acid residues in another glucoamylase. Therefore, all references to positions and specific substitutions refer to the numbering used in SEQ ID NO: 1. However, one skilled in the art will recognize that the sequence of any other sequence disclosed herein can also be used to identify the corresponding amino acid residues in another glucoamylase polypeptide. The amino acid sequence of another glucoamylase is aligned with the polypeptide disclosed in SEQ ID NO: 1, and based on the alignment, the amino acid position number corresponding to any amino acid residue in the polypeptide disclosed in SEQ ID No: 1 is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453), as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, Trends Genet. 16: 276-277) (preferably version 5.0.0 or later). The parameters used are a gap opening penalty of 10, a gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix.
[0056] For proteins of known structure, there are several tools and resources that can be used to retrieve and generate structural alignments. For example, the SCOP superfamily of proteins has been structurally aligned, and those alignments are accessible and downloadable. Multiple algorithms such as distance alignment matrices (Holm and Sander, 1998, Proteins 33:88-96) or combinatorial extensions (Shindyalov and Bourne, 1998, Protein Engineering 11:739-747) can be used to align two or more protein structures, and the implementation of these algorithms can be used in addition to query structural databases with target structures to find possible structural homologues (e.g., Holm and Park, 2000, Bioinformatics 16:566-567).
[0057] In describing the variants of the present invention, the nomenclature described below has been adapted for ease of reference. Accepted IUPAC single-letter or three-letter amino acid abbreviations are used.
[0058] replace.For amino acid substitutions, the following nomenclature is used: original amino acid, position, substituted amino acid. Accordingly, the substitution of threonine at position 226 by alanine is represented as "Thr226Ala" or "T226A". Multiple mutations are separated by a plus sign ("+"), for example, "Gly205Arg+Ser411Phe" or "G205R+S411F" represents that glycine (G) and serine (S) at position 205 and position 411 are replaced by arginine (R) and phenylalanine (F), respectively.
[0059] Missing For amino acid deletions, the following nomenclature is used: original amino acid, position, * Accordingly, the deletion of glycine at position 195 is indicated as "Gly195*" or "G195*". Multiple deletions are separated by plus signs ("+"), for example, "Gly195*+Ser411*" or "G195*+S411*".
[0060] insert. For amino acid insertions, the following nomenclature is used: original amino acid, position, original amino acid, inserted amino acid. Accordingly, the insertion of lysine after glycine at position 195 is represented as "Gly195GlyLys" or "G195GK". Insertions of multiple amino acids are represented as [original amino acid, position, original amino acid, inserted amino acid #1, inserted amino acid #2; etc.]. For example, the insertion of lysine and alanine after glycine at position 195 is represented as "Gly195GlyLysAla" or "G195GKA".
[0061] In such a case, the inserted one or more amino acid residues are numbered by adding lower case letters to the position number of the amino acid residue preceding the inserted one or more amino acid residues. In the above example, the sequence would therefore be:
[0062] <![CDATA[ Parents: ]]> <![CDATA[ Variants: ]]> 195 195 195a 195b G GKA
[0063] Multiple changes Variants containing multiple alterations are separated by plus signs ("+"), for example, "Arg170Tyr+Gly195Glu" or "R170Y+G195E" represent that arginine at position 170 and glycine at position 195 are replaced by tyrosine and glutamic acid, respectively.
[0064] Different changes. Where different changes can be introduced at one position, the different changes are separated by commas, e.g., "Arg170Tyr,Glu" represents that the arginine at position 170 is replaced by tyrosine or glutamic acid. Thus, "Tyr167Gly, Ala+Arg170Gly, Ala" represents the following variants:
[0065] "Tyr167Gly+Arg170Gly", "Tyr167Gly+Arg170Ala", "Tyr167Ala+Arg170Gly", and "Tyr167Ala+Arg170Ala". DETAILED DESCRIPTION
[0067] A first aspect relates to a method for producing a steamed flour product, the method comprising:
[0068] a) providing a dough or batter comprising flour and a glucoamylase having at least 70% identity to SEQ ID NO: 1, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8; and
[0069] b) steaming the dough or the batter to produce a steamed flour product.
[0070] In a preferred embodiment of the present invention, the glucoamylase is a mature thermostable variant of a parent glucoamylase.
[0071] A second aspect of the invention relates to a dough premix or batter premix comprising a dough or batter as defined in the present invention and a mature thermostable variant of a parent glucoamylase.
[0072] In a preferred embodiment of the present invention, the steamed flour product of the present invention has reduced hardness and / or improved elasticity, and thus improved storage stability, after storage at room temperature or at a low temperature of 4°C for 0.1, 0.25, 0.5, 1, 2, 3, 4, 5, 6 or 7 days, or at -20°C for up to 1, 2, 3, 4, 5, 6 months, compared to otherwise identical conditions but without the addition of enzymes to the dough / batter.
[0073] In a preferred embodiment of the present invention, the steamed flour product of the present invention has improved sensory evaluation after storage at room temperature or at a low temperature of 4°C for 0.1, 0.25, 0.5, 1, 2, 3, 4, 5, 6 or 7 days, or at -20°C for up to 1, 2, 3, 4, 5, 6 months, compared to other conditions being the same but without the addition of enzymes to the dough / batter.
[0074] In a preferred embodiment of the present invention, the steamed flour product of the present invention is re-steamed after storage at room temperature or at a low temperature of 4°C for 0.1, 0.25, 0.5, 1, 2, 3, 4, 5, 6 or 7 days, or at -20°C for up to 1, 2, 3, 4, 5, 6 months, compared to other conditions being the same but without adding enzymes to the dough / batter, and the re-steamed product has improved sensory evaluation.
[0075] In a preferred embodiment of the present invention, the sensory evaluation is a comprehensive evaluation of the softness, elasticity, appearance whiteness, crumb structure, moistness, cohesiveness, chewiness and / or sweetness of the steamed flour product, preferably an average value.
[0076] In another preferred embodiment of the present invention, the steamed flour product has at least the same sweetness or sweetness as a control product made with twice the amount of mature glucoamylase, the amino acid sequence of which is shown in SEQ ID NO:10.
[0077] Another aspect relates to a method for producing a cooked flour product, the method comprising:
[0078] a) providing a dough comprising flour and a glucoamylase having at least 70% identity to SEQ ID NO: 1, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8; and
[0079] b) cooking the dough to produce the cooked flour product.
[0080] In a preferred embodiment of the present invention, the glucoamylase is a mature thermostable variant of a parent glucoamylase.
[0081] Steamed flour products:
[0082] As used herein, "steamed flour product" means any flour product prepared by steaming dough or batter. Examples of steamed flour products include steamed bread, such as northern Chinese steamed bread and southern Chinese steamed bread, steamed buns (steamed buns), steamed flower rolls (flower rolls), steamed rolls (rolls), steamed dumplings, steamed noodles (stewed noodles), steamed rice cakes (nian gao), steamed steamed cakes (steamed cakes) or steamed rice cakes (rice cakes). Steamed flour products may contain one or more additional ingredients, such as meat (e.g., pork, beef, chicken or fish), vegetables (e.g., mushrooms, broccoli and other green vegetables), fruits (e.g., dates and jujubes), candies, cheeses and milk (or other dairy products) and combinations thereof.
[0083] The present invention relates to dough or batter comprising a thermostable glucoamylase of the present invention. As used herein, "dough" means any dough for preparing steamed flour products (e.g., steamed bread). The dough for preparing steamed flour products can be made from any suitable flour source, such as flour derived from cereals, such as wheat flour, corn flour, rye flour, barley flour, oat flour, rice flour, or sorghum flour, potato flour, and combinations thereof (e.g., wheat flour combined with one of the other flour sources; rice flour combined with one of the other flour sources).
[0084] The dough of the present invention is usually a fermented dough or a dough to be fermented. The dough can be fermented in various ways, for example by adding dough ingredients such as chemical leavening agents (e.g. sodium bicarbonate) or by adding a leavening agent (fermented dough), but preferably by adding a suitable yeast culture such as a culture of Saccharomyces cerevisiae to ferment the dough.
[0085] The present invention relates to a flour premix comprising a thermostable glucoamylase of the present invention, such a flour premix may comprise any suitable flour source, for example flour derived from a cereal, such as wheat flour, corn flour, rye flour, barley flour, oat flour, rice flour, or sorghum flour, potato flour, and combinations thereof (e.g., wheat flour in combination with one of the other flour sources; rice flour in combination with one of the other flour sources).
[0086] Methods for preparing steamed bread are well known in the art and include, for example, a "straight dough process" and a "sponge and dough process", non-limiting examples of which are provided in the "Materials and Methods" section below. The method for preparing steamed bread generally involves the following sequential steps: making dough (with an optional proofing step), sheeting the dough, shaping, proofing, and then steaming, which are well known in the art. If the optional proofing step is used, more flour is preferably added and a base may be added to neutralize the acid produced or to be produced during the second proofing step.
[0087] Methods for preparing steamed safflower cakes are well known in the art and include, for example, methods for preparing steamed safflower cakes, the methods comprising preparing a batter from a material containing flour, fermenting, and steaming to make the steamed safflower cakes. Preferably, the batter is a rice batter. Preferably, the flour can be from cereals, such as wheat flour, corn flour, rye flour, barley flour, oat flour, rice flour, or sorghum flour, potato flour, and combinations thereof.
[0088] Preferably, the prepared satsuma has a fine mesh structure, a soft mouthfeel, a pleasant wine aroma, and a lactic acid aroma produced by fermentation. Preferably, the batter contains a thermostable glucoamylase of the present invention. Preferably, the steamed satsuma is made from rice, for example, the method comprising: soaking the rice in water, grinding the soaked rice and sieving to obtain a rice batter, or making a rice batter by adding water to a steamed satsuma premix powder, and fermenting the rice batter at 30°C-40°C for about 1-25 hours, then sucrose and baking powder may be added, the mixture is uniformly mixed and steamed for about 15 minutes to make the steamed satsuma. As is well known in the art, the batter is usually fermented by adding a suitable yeast culture such as a culture of Saccharomyces cerevisiae (baker's yeast) or a chemical leavening agent.
[0089] In addition to preparing fresh steamed bread dough or steamed bread products, the present invention relates to a method for preparing frozen steamed bread dough. Frozen steamed bread dough can be advantageous for storage and / or distribution. An example of a method for preparing frozen steamed bread dough comprises the steps of making dough (with optional proofing), sheeting, shaping, proofing, and freezing the dough. The present invention also relates to frozen steamed bread dough comprising a thermostable glucoamylase of the present invention.
[0090] The present invention is particularly useful for preparing steamed bread dough and steamed bread products in an industrialized process, i.e., wherein the dough used to prepare steamed bread and / or steamed bread products is mechanically prepared using automated or semi-automated equipment. The present invention provides a significant advantage in that steamed bread can now be prepared using an automated or semi-automated process, wherein the steamed bread can be stored for more than 24 hours after preparation for distribution and consumer use, but substantially retains the quality of freshly prepared steamed bread that day.
[0091] The method of preparing steamed bread generally involves the following sequential steps: making dough (and optional proofing step), sheeting, shaping, proofing, steaming and packaging. If the optional proofing step is used, more flour is preferably added and alkali may be added to neutralize the acid produced or to be produced during the second proofing step. In the industrial steamed bread production method according to the present invention, one or more of the steps such as sheeting, shaping, proofing, steaming and / or packaging are performed using automated or semi-automated equipment.
[0092] In an embodiment the glucoamylase according to the present invention can be added to flour or dough or batter in an amount of 0.01-1,000 mg enzyme protein (mg EP) / kg flour, preferably in an amount of 0.01-500 mg enzyme protein (mg EP) / kg flour, even more preferably in an amount of 0.1-100 mg enzyme protein (mg EP) / kg flour.
[0093] Cooked flour products:
[0094] As used herein, "cooked flour products" means any flour products prepared by cooking dough. Examples of cooked flour products include traditional Chinese staple foods (e.g., noodles, dumplings and wontons, rice dumplings and rice noodles), and dry products (e.g., dry noodles and semi-dry noodles, hot dry noodles, dry rice noodles and semi-dry rice noodles and wet rice noodles). Flour can be made from any suitable flour source, such as flour derived from cereals, such as rice flour, wheat flour, buckwheat flour, purple rice flour, corn flour, rye flour, barley flour, oat flour, or sorghum flour, potato flour and combinations thereof (e.g., wheat flour combined with one of the other flour sources; rice flour combined with one of the other flour sources). It can be a product with filling or a product without filling. The filling can be meat, vegetables, beans or a combination thereof. The dough of such products is usually not fermented by yeast. The obtained dough can be processed into products of different shapes by different methods, which can be filled or without filling.
[0095] Before eating, the cooked flour products are usually cooked for an appropriate time according to the thickness of the product, whether it has fillings, and the frozen or dry state. Different products are cooked in boiling water for 3-20 minutes to achieve complete gelatinization.
[0096] In an embodiment the glucoamylase according to the present invention can be added to flour or dough in an amount of 0.01-1,000 mg enzyme protein (mg EP) / kg flour, preferably 0.01-500 mg enzyme protein (mg EP) / kg flour, even more preferably 0.1-100 mg enzyme protein (mg EP) / kg flour.
[0097] Glucoamylase
[0098] According to the present invention, different types of glucoamylases can be used as parents for producing thermostable glucoamylase variants, for example, the glucoamylase can be a polypeptide encoded by a DNA sequence found in a fungal strain of Aspergillus, Rhizopus, or Talaromyces or Penicillium; preferably a DNA sequence found in a fungal strain of Penicillium, even more preferably a DNA sequence found in a fungal strain of Penicillium oxysporum, Penicillium oxalicum, Penicillium mikroker, Penicillium roqueforti or Penicillium luminosporum. Examples of other suitable fungi include Aspergillus niger, Aspergillus awamori, Aspergillus oryzae, Rhizopus delemar, Rhizopus niveus, Rhizopus oryzae, and Talaromyces emersonii.
[0099] The parent glucoamylase can be obtained from microorganisms of any genus. For the purposes of the present invention, as used in the present invention in conjunction with a given source, the term "obtained from" shall mean that the parent encoded by the polynucleotide is produced by the source or by a strain into which the polynucleotide from the source has been inserted. In one aspect, the parent is secreted extracellularly.
[0100] In one aspect of the invention, the glucoamylase or a parent glucoamylase can be obtained from Penicillium (eg, Penicillium oxalicum, Penicillium luminosporum, Penicillium brasiliensis, Penicillium roqueforti, Penicillium miekeri).
[0101] In one aspect, the parent fungal glucoamylase can be a Penicillium glucoamylase, e.g., Penicillium oxalicum glucoamylase, Penicillium luminosporum glucoamylase, Penicillium brasiliensis glucoamylase, Penicillium roqueforti glucoamylase, Penicillium mickii glucoamylase.
[0102] In another aspect, the parent glucoamylase is obtained from Penicillium oxalicum, e.g., the glucoamylase shown in SEQ ID NO: 1. In another aspect, the parent glucoamylase is obtained from Penicillium oxalicum, e.g., the glucoamylase shown in SEQ ID NO: 6. In another aspect, the parent glucoamylase is obtained from Penicillium oxalicum, e.g., the glucoamylase shown in SEQ ID NO: 7. In another aspect, the parent glucoamylase is obtained from Penicillium oxalicum, e.g., the glucoamylase shown in SEQ ID NO: 8.
[0103] In one embodiment the thermostable glucoamylase of the invention has at least 70% identity to SEQ ID NO: 1, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8, e.g., at least 71%, such as at least 72%, such as at least 73%, such as at least 74%, such as at least 75%, such as at least 76%, such as at least 77%, such as at least 78%, such as at least 79%, such as at least 80%, such as at least 81%, such as at least 82%, such as at least 83%, such as at least 84%, such as at least 85%, such as at least 86%, such as at least 87%, such as at least 88%, such as at least 89%, such as at least 90%, such as at least 91%, such as at least 92%, such as at least 93%, such as at least 94%, such as at least 95%, such as at least 96%, such as at least 97%, such as at least 98%, such as at least 99% identity to SEQ ID NO: 1, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8. In an embodiment the glucoamylase is a glucoamylase variant or a mature thermostable variant of a parent glucoamylase.
[0104] In one embodiment, the mature variant comprises at least one amino acid modification at one or more (several) or all of the positions corresponding to positions 1, 2, 4, 6, 7, 11, 31, 34, 65, 79, 103, 132, 327, 445, 447, 481, 566, 568, 594, and 595 in SEQ ID NO: 1.
[0105] In one embodiment, the at least one amino acid modification comprises a substitution at one or more or all of the positions corresponding to positions 1, 2, 4, 11, 65, 79 and 327 in SEQ ID NO: 1, preferably, the at least one amino acid modification comprises a substitution at one or more or all of the positions corresponding to R1A, P2N, P4S, P11F, T65A, K79V and Q327F in SEQ ID NO: 1.
[0106] In one embodiment, the at least one amino acid modification comprises a substitution at one or more or all of the positions corresponding to positions 1, 6, 7, 31, 34, 79, 103, 132, 445, 447, 481, 566, 568, 594 and 595 in SEQ ID NO: 1, preferably, the at least one amino acid modification comprises a substitution at one or more or all of the positions corresponding to R1A, G6S, G7T, R31F, K34Y, K79V, S103N, A132P, D445N, V447S, S481P, D566T, T568V, Q594R and F595S in SEQ ID NO: 1.
[0107] In one embodiment, the at least one amino acid modification comprises a substitution at one or more or all of the positions corresponding to positions 1, 6, 7, 31, 34, 50, 79, 103, 132, 445, 447, 481, 484, 501, 539, 566, 568, 594 and 595 in SEQ ID NO: 1, preferably, the at least one amino acid modification comprises a substitution at one or more or all of the positions corresponding to R1A, G6S, G7T, R31F, K34Y, E50R, K79V, S103N, A132P, D445N, V447S, S481P, T484P, E501A, N539P, D566T, T568V, Q594R and F595S in SEQ ID NO: 1.
[0108] In one embodiment, wherein the mature thermostable variant has an improvement in thermostability (Td) of at least 3°C, preferably at least 4°C, 5°C, 6°C, 7°C or 8°C relative to its parent.
[0109] In one embodiment, wherein the mature thermostable variant has a relative activity of at least 150, preferably at least 200, more preferably at least 250, most preferably at least 300 at 91°C compared to its parent.
[0110] In one embodiment, the thermostable glucoamylase is a glucoamylase variant. In one embodiment, the glucoamylase variant of the invention has at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% or 100% sequence identity to the polypeptide of SEQ ID NO: 1 or SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8, and these polypeptides have glucoamylase activity.
[0111] In one embodiment, the amino acid sequence of the glucoamylase variant or the glucoamylase variant of the invention differs from SEQ ID NO: 1, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8, or the mature polypeptide of SEQ ID NO: 1, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8 by no more than ten amino acids, such as nine amino acids, eight amino acids, seven amino acids, six amino acids, five amino acids, four amino acids, three amino acids, two amino acids, and one amino acid. In one embodiment, the mature polypeptide of SEQ ID NO: 1, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8 is as shown in SEQ ID NO: 1, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8.
[0112] In one embodiment, the amino acid sequence of the glucoamylase, glucoamylase variant or glucoamylase variant of the invention comprises or consists of the amino acid sequence of SEQ ID NO:1, SEQ ID NO:6, SEQ ID NO:7 or SEQ ID:8.
[0113] The amino acid changes in the variants may be of a minor nature, i.e., conservative amino acid substitutions or insertions that do not significantly affect the folding and / or activity of the protein; small deletions, typically of 1-30 amino acids; small amino-terminal or carboxyl-terminal extensions, such as an amino-terminal methionine residue; small linker peptides of up to 20-25 residues; or small extensions that facilitate purification by altering the net charge or another function, such as a polyhistidine stretch, an antigenic epitope, or a binding domain.
[0114] Examples of conservative substitutions are within the group consisting of basic amino acids (arginine, lysine, and histidine), acidic amino acids (glutamic acid and aspartic acid), polar amino acids (glutamine and asparagine), hydrophobic amino acids (leucine, isoleucine, and valine), aromatic amino acids (phenylalanine, tryptophan, and tyrosine), and small amino acids (glycine, alanine, serine, threonine, and methionine). Amino acid substitutions that generally do not alter specific activity are known in the art and are described, for example, by H. Neurath and RL Hill, 1979, in The Proteins, Academic Press, New York. Common substitutions are Ala / Ser, Val / Ile, Asp / Glu, Thr / Ser, Ala / Gly, Ala / Thr, Ser / Asn, Ala / Val, Ser / Gly, Tyr / Phe, Ala / Pro, Lys / Arg, Asp / Asn, Leu / Ile, Leu / Val, Ala / Glu, and Asp / Gly.
[0115] Alternatively, these amino acid changes have such a property that the physicochemical properties of the polypeptide are changed. For example, amino acid changes can improve the thermal stability of the polypeptide, change the substrate specificity, change the optimal pH, etc.
[0116] Essential amino acids in a polypeptide can be identified according to procedures known in the art, such as site-directed mutagenesis or alanine scanning mutagenesis (Cunningham and Wells, 1989, Science 244: 1081-1085). In the latter technique, single alanine mutations are introduced at every residue in the molecule, and the resulting mutant molecules are tested for glucoamylase activity to identify amino acid residues that are critical to the activity of the molecule. See also, Hilton et al., 1996, J. Biol. Chem. 271: 4699-4708. Active sites of enzymes or other biological interactions can also be determined by physical analysis of the structure, such as by techniques such as nuclear magnetic resonance, crystallography, electron diffraction, or photoaffinity labeling, together with mutations to putative contact site amino acids. See, e.g., de Vos et al., 1992, Science 255:306-312; Smith et al., 1992, J. Mol. Biol. 224:899-904; Wlodaver et al., 1992, FEBS Lett. 309:59-64. The identities of essential amino acids can also be inferred from alignments with related polypeptides.
[0117] The following shows Figure 1 The % identity between the AMG amino acid sequences aligned in , and are also provided in the sequence listing:
[0118]
[0119] Thermostable variants of PoAMG have been generated (see Table 2 below).In preferred embodiments, the mature thermostable glucoamylase variants of the invention comprise one or more or all combinations of the amino acid substitutions listed in Table 2 below.
[0120] The improved thermostability (Td) of the variants in Table 2 are listed in Table 3, wherein the Td of the PoAMG variant denoted "anPAV498" (parent) is set to zero. In preferred embodiments, the mature thermostable variants of the invention have an improved thermostability (Td) of at least 3°C, preferably at least 4°C, 5°C, 6°C, 7°C or 8°C relative to their parent, preferably as determined as exemplified herein.
[0121] In another preferred embodiment, the mature thermostable variant of the present invention has a relative activity of at least 150, preferably at least 200, more preferably at least 250, most preferably at least 300 at 91°C compared to its parent.
[0122] Other enzymes
[0123] Optionally, one or more additional enzymes (such as α-amylase, maltogenic amylase, β-amylase, aminopeptidase, carboxypeptidase, catalase, cellulolytic enzyme, chitinase, cutinase, cyclodextrin glycosyltransferase, deoxyribonuclease, esterase, glucan 1,4-α-maltotetraosyl hydrolase, glucanase, galactanase, α-galactosidase, β-galactosidase, glucose oxidase, α-glucosidase, β-glucosidase, haloperoxidase, hemicellulolytic enzyme, invertase, laccase, lipase, mannanase, mannosidase, oxidase, pectinolytic enzyme, peptidoglutaminase, peroxidase, phospholipase, phytase, polyphenol oxidase, proteolytic enzyme, ribonuclease, transglutaminase and xylanase) can be used with the glucoamylase of the invention.
[0124] The one or more additional enzymes may be of any origin, including mammalian origin, plant origin, and microbial (bacterial, yeast or fungal) origin.
[0125] Enzyme composition
[0126] The mature thermostable glucoamylase variants of the invention and any one or more additional enzymes can be added to the flour or dough in any suitable form, for example in the form of a liquid (particularly a stabilized liquid), or can be added to the flour or dough as a substantially dry powder or granules.
[0127] For example, granules may be produced as disclosed in U.S. Pat. No. 4,106,991 and U.S. Pat. No. 4,661,452. Liquid enzyme preparations may be stabilized, for example, by adding sugars or sugar alcohols or lactic acid according to established procedures. Other enzyme stabilizers are well known in the art.
[0128] The one or more enzymes can be added to the dough ingredients in any suitable manner, such as as separate components (adding the enzymes separately or sequentially), or adding the enzymes together in one step or one combination.
[0129] The invention described and claimed herein is not limited in scope to the specific embodiments disclosed herein, as these embodiments are intended as illustrative illustrations of several aspects of the invention. Any equivalent embodiments as well as combinations of one or more of these embodiments are intended to be within the scope of the invention.
[0130] Various references are cited herein, the disclosures of which are incorporated by reference in their entireties.The present invention is further described by the following examples, which should not be construed as limiting the scope of the invention.
[0131] Examples
[0132] Example 1: Construction of PoAMG library
[0133] The PoAMG library was constructed as follows:
[0134] Design the forward or reverse primer with NNK or one or more desired mutations at one or more target sites, and these target sites have an overlap of 15bp each other. Use appropriate template plasmid DNA (for example, plasmid DNA containing JPO-0001 gene) to carry out inverse PCR under the following conditions, i.e., amplify the whole plasmid DNA sequence by reverse directional primer. Purify the gained PCR fragment by QIAquick gel extraction kit [Qiagen (QIAGEN)], then introduce it into Escherichia coli ECOS competent Escherichia coli DH5α [Japan Gene Co., Ltd. (NIPPON GENE CO., LTD.)]. Extract plasmid DNA from Escherichia coli transformant by MagExtractor plasmid extraction kit [Toyo Company (TOYOBO)], then introduce it into Aspergillus niger competent cell.
[0135] PCR reaction mixture:
[0136] PrimeSTAR Max DNA Polymerase [TaKaRa]
[0137] Total 25 μl
[0138] 1.0μl template DNA (1ng / μl)
[0139] 9.5 μl HO
[0140] 12.5 μl 2x PrimeSTAR Max premix
[0141] 1.0μl forward primer (5μM)
[0142] 1.0μl reverse primer (5μM)
[0143] PCR procedure:
[0144] 98℃ / 2min
[0145] 25x(98℃ / 10sec, 60℃ / 15sec, 72℃ / 2min)
[0146] 10℃ / maintain
[0147] Example 2: Screening for better thermal stability
[0148] The Bacillus subtilis library constructed as in Example 1 was fermented in a 96-well or 24-well MTP containing COVE liquid medium (2.0 g / L sucrose, 2.0 g / L isomaltose, 2.0 g / L maltose, 4.9 mg / L, 0.2 ml / L 5N NaOH, 10 ml / L COVE salts, 10 ml / L 1 M acetamide) at 32° C. for 3 days. AMG activity in the culture supernatant was then measured at several temperatures by the pNPG assay as described below.
[0149] pNPG thermal stability assay:
[0150] The culture supernatant containing the desired enzyme was mixed with the same volume of pH 5.0 200mM NaOAc buffer. Twenty microliters of the mixture was distributed in a 96-well plate or 8-link PCR tubes and then heated for 30 minutes at various temperatures by a thermal cycler. Those samples were mixed with 10 μl of substrate solution containing 0.1% (w / v) pNPG [Wako Co., Ltd. (wako)] in pH 5.0 200mM NaOAc buffer and incubated at 70°C for 20 minutes for enzyme reaction. After the reaction, 60 μl of 0.1M Borax buffer was added to stop the reaction. 80 μl of the reaction supernatant was taken out and its OD was read by a photometer. 405 to evaluate enzyme activity.
[0151] Table 1a. List of relative activities of PoAMG variants compared to their parents anPAV498 or JPO-0001 (anPAV498 with leader / propeptide)
[0152] name Relative activity at 80℃ / 75℃ (%) anPAV498 17% JPO-004 32% JPO-005 15% JPO-006 16% JPO-007 3%
[0153] name Relative activity at 80℃ / 75℃ (%) AnPav498 13% JPO-009 16% JPO-011 15% JPO-012 15% JPO-013 17% JPO-020 20%
[0154] name Relative activity at 80℃ / 70℃ (%) JPO-001 10% JPO-004 29% JPO-009 13% JPO-014 21% JPO-020 16% JPO-021 30% JPO-052 33%
[0155] name Relative activity at 79℃ / 70℃ (%) JPO-001 23% JPO-021 46% JPO-022 39% JPO-023 44% JPO-025 51% JPO-027 49% JPO-029 37%
[0156] name Relative activity at 77℃ / 70℃ (%) JPO-001 72% JPO-029 82% JPO-047 80% JPO-048 90% JPO-049 84% JPO-050 86% JPO-064 87%
[0157] name Relative activity at 79℃ / 77℃ (%) JPO-001 36% JPO-029 51% JPO-047 45% JPO-048 81% JPO-049 53% JPO-050 58% JPO-064 65%
[0158] name Relative activity at 79℃ / 77℃ (%) JPO-001 41% JPO-021 60% JPO-022 48% JPO-023 57% JPO-025 56% JPO-027 64% JPO-029 66% JPO-047 50% JPO-048 72% JPO-051 82% JPO-058 73% JPO-062 72% JPO-063 85% JPO-064 83%
[0159] Table 1b. List of relative activities of PoAMG variants compared to their parent JPO-022
[0160]
[0161]
[0162] name Relative activity at 77℃ / 70℃ (%) JPO-022 76% JPO-023 75% JPO-025 80% JPO-027 84% JPO-058 92% JPO-059 88% JPO-060 86% JPO-061 83% JPO-062 87%
[0163] name Relative activity at 79℃ / 77℃ (%) JPO-022 49% JPO-023 51% JPO-025 52% JPO-027 58% JPO-058 69% JPO-059 36% JPO-060 41% JPO-061 44% JPO-062 57%
[0164] Table 1c. List of relative activities of PoAMG variants compared to their parent JPO-063
[0165]
[0166]
[0167] name Relative activity at 84℃ / 80℃ (%) JPO-063 16% JPO-065 26% JPO-067 21% JPO-070 12% JPO-071 13% JPO-074 32% JPO-081 17% JPO-082 24% JPO-083 46% JPO-084 26% JPO-044 37%
[0168] name Relative activity at 82℃ / 70℃ (%) JPO-063 21% JPO-093 43% JPO-081 25% JPO-088 39% JPO-094 38% JPO-096 38% JPO-106 53%
[0169] name Relative activity at 83℃ / 80℃ (%) JPO-063 46% JPO-051 44% JPO-096 64% JPO-106 88% JPO-110 81% JPO-111 100% JPO-112 86% JPO-113 83% JPO-114 47% JPO-115 90%
[0170] Table 1d. List of relative activities of PoAMG variants compared to their parent JPO-096
[0171] name Relative activity at 83℃ / 70℃ (%) JPO-082 53% JPO-088 70% JPO-091 69% JPO-092 65% JPO-093 62% JPO-094 74% JPO-095 69% JPO-096 67% JPO-097 65% JPO-098 65%
[0172]
[0173]
[0174] Table 1e. List of relative activities of PoAMG variants compared to their parent JPO-129
[0175] name Relative activity at 84℃ / 80℃ (%) JPO-129 62% JPO-156 51% JPO-160 34% JPO-161 41% JPO-162 49% JPO-163 21% JPO-164 57% JPO-165 77%
[0176] Table 1f. List of relative activities of PoAMG variants compared to their parent JPO-166
[0177] name Relative activity at 84℃ / 75℃ (%) JPO-166 19% JPO-167 66% JPO-168 58% JPO-169 53% JPO-171 47% JPO-172 98%
[0178] Table 2. Amino acid substitutions in variants of the PoAMG mature sequence
[0179]
[0180]
[0181]
[0182]
[0183]
[0184]
[0185] Example 3: Fermentation of Aspergillus niger
[0186] Aspergillus niger strains were fermented in 500 ml baffled flasks containing 100 ml MU1 and 4 ml 50% urea on an orbital shaker at 220 rpm and 30° C. The culture broth was centrifuged (10,000×g, 20 min) and the supernatant was carefully decanted from the precipitate.
[0187] Example 4: Purification of PoAMG (JPO-001) variants
[0188] PoAMG variants were purified by cation exchange chromatography. The respective peak fractions were combined individually and dialyzed against 20 mM sodium acetate buffer (pH 5.0), and the samples were then concentrated using a centrifugal filter device (Vivaspin Turbo 15, Sartorius). The enzyme concentration was determined by the A280 value.
[0189] Example 5: Thermal Stability Assay (TSA)
[0190] The purified enzyme was diluted to 0.5 mg / ml with 50 mM sodium acetate buffer (pH 5.0) and mixed with an equal volume of SYPRO Orange (Invitrogen) diluted with Milli-Q water. 18 μl of the mixture solution was transferred to a LightCycler 480 multiwell plate 384 (Roche Diagnostics) and the plate was sealed.
[0191] TSA equipment parameters:
[0192] Instrument: LightCycler 480 Real-Time PCR System (Roche Applied Science)
[0193] Scan rate: 0.02℃ / sec
[0194] Scanning range: 37℃-96℃
[0195] Integration time: 1.0 sec
[0196] Excitation wavelength 465nm
[0197] Emission wavelength 580nm
[0198] The obtained fluorescence signals were normalized to the range of 0 and 1. Td was defined as the temperature at which the signal intensity was 0.5. The thermal stability improvements are listed in Table 3, where the Td of the PoAMG variants is indicated as 0 for anPAV498.
[0199] Example 6: PoAMG activity assay
[0200] Determination of maltodextrin (DE11) by GOD-POD method
[0201] Substrate solution
[0202] 30 g maltodextrin (pindex #2 from MATSUTANI chemical industry Co., Ltd.)
[0203] 100 ml 120 mM sodium acetate buffer, pH 5.0
[0204] Glucose CII test kit (Wako Pure Chemical Industries. Ltd., Japan)
[0205] 20 μ l of enzyme sample was mixed with 100 μ l of substrate solution and incubated at set temperature for 2 hours. Sample was cooled on aluminum block for 3 min, then 10 ul of reaction solution was mixed with 590 ul of 1 M Tris-HCl (pH 8.0) to stop the reaction. 10 μ l of solution was mixed with 200 μ l of working solution of test kit and then left at room temperature for 15 min. Read absorbance at A505. Activity is listed in Table 3 as the relative activity of PoAMG variants represented as anPAV498.
[0206] Table 3
[0207]
[0208]
[0209]
[0210]
[0211] Example 7: Use of PoAMG in steamed bread
[0212] Chinese northern steamed bread was prepared by direct fermentation method, and the formula is shown in Table 4 and Table 5. All raw materials used in this article are food grade, using PoAMG variant JPO-172 (75ppm used in this article means 24.45mg EP / 1000g flour) and maltogenic α-amylase, and the maltogenic α-amylase in this article is Novamyl Boost (a commercial product of Novozymes). In short, flour, yeast and steamed bread improver are weighed and put into a dough cylinder (vertical mixer, DIOSNA brand), and then enzymes and water are added. The mixture is stirred at low speed for 6 minutes until the dough is formed and the dough surface is smooth, and the dough is sheeted until the desired degree is reached. The number of sheeting depends on the feel. After sheeting, weigh about 110g of dough and shape it into a steamed bun shape. At 35°C (room humidity is about 80%), the shaped dough is placed in a proofing machine for about 40min. After proofing, the dough is placed in a steamer (100°C) and steamed for 20min. Then, the steam was turned off, and after about 5 min, the steamed buns were taken out and cooled at room temperature for 2 h, after which the prepared steamed buns were packaged in sealed plastic packaging for texture and sensory evaluation.
[0213] Re-steaming of steamed buns: The prepared steamed buns were stored at room temperature for 24 hours, or in a refrigerator at 4°C for 48 hours, and then re-steamed in a steamer (100°C) for about 15 minutes. The steam was then turned off, and after about 5 minutes, the re-steamed buns were taken out for sensory evaluation.
[0214] Table 4. Recipe of northern steamed bread
[0215]
[0216] Table 5:
[0217] batch JPO-172 Novamyl Boost A 0 0 B 75ppm 0 C 0 100ppm
[0218] Sample characterization
[0219] Hardness determination method: Use a slicer to slice the steamed bread (each steamed bread slice is 1.2 cm thick), and use a TA.XT Plus texture analyzer to determine the hardness. The higher the hardness value, the worse the quality of the steamed bread.
[0220] Method for measuring elasticity: Use a slicer to slice the steamed bread (each steamed bread slice is 1.2 cm thick). Two slices of steamed bread are grouped together (2.4 cm thick) and measured using a TA.XT Plus texture analyzer. The unit is %. The higher the elasticity value, the better the quality of the steamed bread.
[0221] Sensory evaluation:
[0222] For sensory evaluation, the quality of the steamed buns / re-steamed buns was evaluated by a panel (5 trained personnel). Parameters such as softness, elasticity, whiteness of appearance, crumb structure, moistness, cohesiveness, chewiness and / or sweetness were scored. The steamed buns prepared in batch A were scored 5.0 points and used as a benchmark. The average value was taken for comprehensive evaluation, where the higher the average score, the better the quality of the steamed buns produced.
[0223] Table 6. Hardness and elasticity of steamed bread after storage at room temperature for 24 hours
[0224] batch Hardness / g elasticity / % A 2655 54.96 B 1512 63.21 C 1691 60.67
[0225] As can be seen from Table 6 below, when PoAMG (JPO-172) and Novamyl Boost were used during the preparation of steamed bread, the hardness of the steamed bread was significantly reduced, and the elasticity of the steamed bread was also improved, compared with the control (Batch A). However, in comparison, PoAMG (JPO-172) showed a better effect than Novamyl Boost.
[0226] The steamed bread prepared in each batch was stored at room temperature for 24 hours and then subjected to sensory evaluation, and the results are shown in Table 7. Compared with the control (batch A), the addition of PoAMG (JPO-172) and Novamyl Boost to the dough improved the sensory evaluation of the steamed bread, such as tactile softness, tactile elasticity, crumb structure, moistness, cohesiveness, and chewiness. In addition, PoAMG (JPO-172) also improved the sweetness of the steamed bread. In contrast, PoAMG (JPO-172) was significantly superior to Novamyl Boost in improving the quality of steamed bread.
[0227] Table 7. Sensory evaluation of steamed bread (after storage at room temperature for 24 hours)
[0228]
[0229] The steamed bread prepared in each batch was stored at room temperature for 24 hours and then re-steamed. After cooling to room temperature, the re-steamed steamed bread was subjected to sensory evaluation. The results are shown in Table 8.
[0230] Table 8. Sensory evaluation of steamed bread (storage at room temperature for 24 hours and then re-steaming)
[0231]
[0232] The steamed bread prepared in each batch was stored at 4° C. for 48 hours and then re-steamed. After cooling to room temperature, the re-steamed steamed bread was subjected to sensory evaluation. The results are shown in Table 9.
[0233] Table 9: Sensory evaluation of steamed bread (storage at 4°C for 48 hours and then re-steamed)
[0234]
[0235] As can be seen from Tables 8 and 9, compared with the control batch A, the addition of PoAMG (JPO-172) to the dough significantly improved the sensory evaluation of the steamed buns after re-steaming, such as tactile softness, tactile elasticity, crumb structure, chewiness and sweetness. PoAMG (JPO-172) also improved the appearance whiteness of the steamed buns after re-steaming. However, in comparison, even with the addition of NovamylBoost, the sensory evaluation of the steamed buns after re-steaming was not good, even worse than batch A.
[0236] Example 8: Use of POAMG in steaming rice cake
[0237] Steamed rice cakes were prepared according to the recipes in Tables 10 and 11. In brief, rice batter was prepared by mixing steamed rice cake premix powder and water in a container. Batch A was a non-enzyme control, and PoAMG (JPO-172) was added to the rice batter as batch B. The mixture was sealed and fermented at 35°C for 16 hours, and sucrose and baking powder were added after fermentation. After that, the fermented mixture was stirred and placed in a mold, and then steamed in a steamer (100°C) for about 15 minutes. The steam was then turned off, and after about 5 minutes, the steamed rice cake was taken out and cooled at room temperature for 3 hours for texture and sensory evaluation.
[0238] Table 10. Recipe for steamed rice cake
[0239]
[0240] Table 11:
[0241] batch content A 0 B 65mg EP / 1000g premix powder
[0242] Method for determining hardness: Cut the surface of the steamed rice cake into a flat surface along the outer edge of the mold (the height of each sample is 2.5 cm), and use a TA.XT Plus texture analyzer to determine the hardness. The higher the hardness value in grams, the worse the quality of the product.
[0243] Method for measuring elasticity: Cut the surface of the steamed rice cake into a plane along the outer edge of the mold (the height of each sample is 2.5 cm), and use a TA.XT Plus texture analyzer to measure the elasticity. The higher the elasticity value, the better the quality of the product.
[0244] Sensory evaluation:
[0245] For sensory evaluation, the quality of steamed rice cakes was evaluated by a panel (5 trained personnel). Parameters such as mouthfeel softness, mouthfeel moistness, mouthfeel elasticity, flesh structure and sweetness were scored. The steamed rice cakes prepared in batch A were scored as 5.0 points and used as a benchmark. The average value was taken for comprehensive evaluation, wherein the higher the average value score, the better the quality of the steamed rice cakes prepared.
[0246] The sensory evaluation of the steamed rice cakes is shown in Table 12. When PoAMG (JPO-172) was added to the batter, the softness, moistness, elasticity and sweetness of the steamed rice cakes were improved without loss of crumb structure.
[0247] Table 12: Sensory evaluation of steamed rice cake
[0248] batch Mouth softness Mouth moistness Elastic taste Crumb structure Sweetness A 5 5 5 5 5 B 6.4 6.1 5.9 5 5.5
[0249] In addition, the results of texture analysis can be seen in Table 13. When PoAMG (JPO-172) is used in the preparation of steamed rice cake, the prepared steamed rice cake has reduced hardness and improved elasticity.
[0250] Table 13. Hardness and elasticity
[0251] batch Hardness / g elasticity / % A 3435.25 74.18 B 1810.09 77.08
Claims
1. A method for producing a steamed flour product, the method comprising: a) providing a dough or batter comprising flour and a glucoamylase having at least 70% identity to SEQ ID NO: 1, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8; and b) steaming the dough to produce a steamed flour product.
2. The method of claim 1, wherein the glucoamylase is a glucoamylase variant or a mature thermostable variant of a parent glucoamylase.
3. The method according to any one of claims 1-2, wherein the steamed flour product is selected from: steamed buns, steamed buns (steamed buns), steamed flower rolls (flower rolls), steamed rolls (rolls), steamed dumplings, steamed noodles (braised noodles), steamed steamed cakes (steamed cakes), steamed rice cakes (rice cakes), and steamed rice cakes (rice cakes).
4. The method according to any one of claims 1-3, wherein the dough or the batter is made of a material containing flour, preferably the flour is selected from the group consisting of wheat flour, corn flour, rye flour, barley flour, oat flour, rice flour, or sorghum flour, potato flour and combinations thereof.
5. The method according to any one of claims 1-4, wherein the parent glucoamylase is obtained from a species of the genus Penicillium, preferably from Penicillium oxalicum, Penicillium miekii, Penicillium roqueforti or Penicillium luminosporum.
6. according to the method described in any one of claims 1-5, wherein the mature variant comprises at least one amino acid modification at one or more (several) or all positions corresponding to positions 1, 2, 4, 6, 7, 11, 31, 34, 65, 79, 103, 132, 327, 445, 447, 481, 566, 568, 594 and 595 in SEQ ID NO:
1.
7. The method according to any one of claims 1 to 6, wherein the at least one amino acid modification comprises a substitution at one or more or all of the positions corresponding to positions 1, 2, 4, 11, 65, 79 and 327 in SEQ ID NO: 1, preferably, the at least one amino acid modification comprises a substitution at one or more or all of the positions corresponding to R1A, P2N, P4S, P11F, T65A, K79V and Q327F in SEQ ID NO:
1.
8. The method according to any one of claims 1 to 7, wherein the at least one amino acid modification comprises a substitution at one or more or all of the positions corresponding to positions 1, 6, 7, 31, 34, 79, 103, 132, 445, 447, 481, 566, 568, 594 and 595 in SEQ ID NO: 1, preferably, the at least one amino acid modification comprises a substitution at one or more or all of the positions corresponding to R1A, G6S, G7T, R31F, K34Y, K79V, S103N, A132P, D445N, V447S, S481P, D566T, T568V, Q594R and F595S in SEQ ID NO:
1.
9. The method according to any one of claims 1 to 8, wherein the at least one amino acid modification comprises a substitution at one or more or all of the positions corresponding to positions 1, 6, 7, 31, 34, 50, 79, 103, 132, 445, 447, 481, 484, 501, 539, 566, 568, 594 and 595 in SEQ ID NO: 1, preferably, the at least one amino acid modification comprises a substitution at one or more or all of the positions corresponding to R1A, G6S, G7T, R31F, K34Y, E50R, K79V, S103N, A132P, D445N, V447S, S481P, T484P, E501A, N539P, D566T, T568V, Q594R and F595S in SEQ ID NO:
1.
10. The method according to any one of claims 1 to 9, wherein the mature thermostable variant has an improvement in thermostability (Td) of at least 3°C, preferably at least 4°C, 5°C, 6°C, 7°C or 8°C relative to its parent.
11. The method according to any one of claims 1 to 10, wherein the mature thermostable variant has a relative activity of at least 150, preferably at least 200, more preferably at least 250, most preferably at least 300 at 91°C compared to its parent.
12. The method according to any one of claims 1 to 11, wherein the glucoamylase, preferably the mature thermostable variant of the parent glucoamylase, has at least 71% identity to SEQ ID NO: 1, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8, NO:8 has, for example, at least 72%, for example at least 73%, for example at least 74%, for example at least 75%, for example at least 76%, for example at least 77%, for example at least 78%, for example at least 79%, for example at least 80%, for example at least 81%, for example at least 82%, for example at least 83%, for example at least 84%, for example at least 85%, for example at least 86%, for example at least 87%, for example at least 88%, for example at least 89%, for example at least 90%, for example at least 91%, for example at least 92%, for example at least 93%, for example at least 94%, for example at least 95%, for example at least 96%, for example at least 97%, for example at least 98%, for example at least 99%, for example at least 100% identity.
13. The method according to any one of claims 1 to 12, wherein: After storage at room temperature or at a low temperature of 4° C. for 0.1, 0.25, 0.5, 1, 2, 3, 4, 5, 6 or 7 days, the steamed flour product has reduced hardness and / or improved elasticity compared to other conditions being the same but without adding the enzyme to the dough / the batter.
14. The method according to any one of claims 1 to 12, wherein: The steamed flour product has improved sensory evaluation values after storage at room temperature or at a low temperature of 4° C. for 0.1, 0.25, 0.5, 1, 2, 3, 4, 5, 6 or 7 days compared to other conditions being the same but without adding the enzyme to the dough / the batter.
15. The method according to any one of claims 1 to 12, wherein: After storage at room temperature or at a low temperature of 4° C. for 0.1, 0.25, 0.5, 1, 2, 3, 4, 5, 6 or 7 days, the steamed flour product is re-steamed, and the steamed flour product after re-steaming has improved sensory evaluation compared to the other conditions being the same but without adding the enzyme to the dough / the batter.
16. The method according to any one of claims 1 to 12, wherein: The sensory evaluation is a comprehensive evaluation of the softness, elasticity, appearance whiteness, crumb structure, moistness, cohesiveness, chewiness and / or sweetness of the steamed flour product or the steamed product after re-steaming, preferably the average value.
17. A flour composition, a dough premix, or a batter premix comprising flour and a thermostable glucoamylase, preferably a mature thermostable variant of a parent glucoamylase as defined in any one of claims 1 to 12.
18. A dough comprising flour and a thermostable glucoamylase, preferably a mature thermostable variant of a parent glucoamylase as defined in any of claims 1-12.
